Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.

The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in ...

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks that nosedived in January, going from $42.98 to $32.75 on ...

Preparing to Initiate Clinical Development in Patients with Hematologic Malignancies in the First Quarter of 2025Series B Financing Funds ...

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...

The US Food and Drug Administration (FDA) has approved two biotech firms, United Therapeutics Corp. and eGenesis, to conduct ...

With Northway Biotech's expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market ...

China Universal Asset Management Co. Ltd. purchased a new position in shares of Rapport Therapeutics (NASDAQ:RAPP – Free Report) during the fourth quarter, according to the company in its most recent ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ transplant.